3rd TRP Target Selection and Drug Design Summit 2027
February 23 - 25, 2027 - MA USHanson Wade
info@hansonwade.com
Phone:+14157353289
Targeted radiopharmaceuticals are entering a new phase of competition and innovation. With 298 programs now in preclinical development, pipelines are expanding rapidly, yet activity remains concentrated around a relatively small number of established targets. As more programs compete for differentiation, the 3rd TRP Target Selection and Drug Design Summit (February 23–25 | Boston) is the only industry-focused meeting purpose-built for drug-developers to understand which targets, isotopes and drug design strategies will define the next generation of clinically and commercially successful radiopharmaceuticals. Join 100+ scientific, technical and strategic leaders across biotech, pharma, regulations and academia to tackle the scientific and strategic challenges underpinning radiopharmaceutical target selection and drug design. Time: 8:00 am to 5:00 pm